Suppr超能文献

口服轮状病毒疫苗的婴儿中的肠套叠。

Intussusception among infants given an oral rotavirus vaccine.

作者信息

Murphy T V, Gargiullo P M, Massoudi M S, Nelson D B, Jumaan A O, Okoro C A, Zanardi L R, Setia S, Fair E, LeBaron C W, Wharton M, Livengood J R

机构信息

Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.

出版信息

N Engl J Med. 2001 Feb 22;344(8):564-72. doi: 10.1056/NEJM200102223440804.

Abstract

BACKGROUND

Intussusception is a form of intestinal obstruction in which a segment of the bowel prolapses into a more distal segment. Our investigation began on May 27, 1999, after nine cases of infants who had intussusception after receiving the tetravalent rhesus-human reassortant rotavirus vaccine (RRV-TV) were reported to the Vaccine Adverse Event Reporting System.

METHODS

In 19 states, we assessed the potential association between RRV-TV and intussusception among infants at least 1 but less than 12 months old. Infants hospitalized between November 1, 1998, and June 30, 1999, were identified by systematic reviews of medical and radiologic records. Each infant with intussusception was matched according to age with four healthy control infants who had been born at the same hospital as the infant with intussusception. Information on vaccinations was verified by the provider.

RESULTS

Data were analyzed for 429 infants with intussusception and 1763 matched controls in a case-control analysis as well as for 432 infants with intussusception in a case-series analysis. Seventy-four of the 429 infants with intussusception (17.2 percent) and 226 of the 1763 controls (12.8 percent) had received RRV-TV (P=0.02). An increased risk of intussusception 3 to 14 days after the first dose of RRV-TV was found in the case-control analysis (adjusted odds ratio, 21.7; 95 percent confidence interval, 9.6 to 48.9). In the case-series analysis, the incidence-rate ratio was 29.4 (95 percent confidence interval, 16.1 to 53.6) for days 3 through 14 after a first dose. There was also an increase in the risk of intussusception after the second dose of the vaccine, but it was smaller than the increase in risk after the first dose. Assuming full implementation of a national program of vaccination with RRV-TV, we estimated that 1 case of intussusception attributable to the vaccine would occur for every 4670 to 9474 infants vaccinated.

CONCLUSIONS

The strong association between vaccination with RRV-TV and intussusception among otherwise healthy infants supports the existence of a causal relation. Rotavirus vaccines with an improved safety profile are urgently needed.

摘要

背景

肠套叠是一种肠梗阻形式,即一段肠管套入更远处的肠管。1999年5月27日,在有9例接种四价恒河猴 - 人重配轮状病毒疫苗(RRV-TV)后发生肠套叠的婴儿病例报告至疫苗不良事件报告系统后,我们展开了调查。

方法

在19个州,我们评估了至少1个月但不满12个月的婴儿中RRV-TV与肠套叠之间的潜在关联。通过系统查阅医疗和放射学记录,确定了1998年11月1日至1999年6月30日期间住院的婴儿。每例肠套叠婴儿均按照年龄与4名在同一医院出生的健康对照婴儿匹配。疫苗接种信息由提供方核实。

结果

在病例对照分析中,对429例肠套叠婴儿和1763例匹配对照进行了数据分析,在病例系列分析中对432例肠套叠婴儿进行了分析。429例肠套叠婴儿中有74例(17.2%),1763例对照中有226例(12.8%)接种了RRV-TV(P = 0.02)。病例对照分析发现,首次接种RRV-TV后3至14天肠套叠风险增加(调整后的优势比为21.7;95%置信区间为9.6至48.9)。在病例系列分析中,首次接种后第3至14天的发病率比为29.4(95%置信区间为16.1至53.6)。第二次接种疫苗后肠套叠风险也有所增加,但小于首次接种后的增加幅度。假设全面实施全国性RRV-TV疫苗接种计划,我们估计每4670至9474名接种疫苗的婴儿中会有1例肠套叠可归因于该疫苗。

结论

在其他方面健康的婴儿中,RRV-TV疫苗接种与肠套叠之间的强关联支持因果关系的存在。迫切需要安全性更高的轮状病毒疫苗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验